Healthcare Triangle, Inc. (NASDAQ: HCTI) and its subsidiary QuantumNexis announced a joint venture with Saudi‑based Golden Code Holdings to deliver AI‑powered digital health platforms across hospitals, clinics and enterprise health groups in the Kingdom. The partnership will deploy QuantumNexis’s CloudEz, DataEz, Readabl.AI, Ezovion and Ziloy.ai solutions, aligning with Saudi Vision 2030 and the Ministry of Health’s digital strategy.
The joint venture combines QuantumNexis’s global AI and interoperability expertise with Golden Code’s local market presence and investment capacity, positioning HCTI to tap into a projected $70 billion Saudi healthcare market by 2030. It expands HCTI’s Middle East footprint and supports the company’s shift toward recurring managed services and platform offerings, creating new subscription revenue opportunities.
HCTI has faced declining revenues and losses, reporting a Q3 2025 EPS of –$0.42. The partnership is part of a broader strategy to generate new recurring revenue streams and improve profitability. The $50 million acquisition of Spanish AI firms in January 2026 has already begun to shift the company’s financial trajectory, providing a foundation for the new venture.
CFO David Ayanoglou said the joint venture “will accelerate our AI platform monetization in a high‑growth market.” QuantumNexis President Kathir K. described the venture as a “defining moment” for global expansion, while Golden Code Director Mustafa Razza emphasized alignment with Saudi Arabia’s commitment to digital health innovation.
The partnership signals HCTI’s continued focus on AI‑driven solutions and its ambition to become a key player in the Middle East. While the joint venture’s financial terms are undisclosed, the collaboration is expected to create new recurring revenue opportunities and strengthen HCTI’s competitive position against larger incumbents.
HCTI’s management remains cautious about the timing of revenue realization, noting that deployment timelines and regulatory approvals will shape the pace of growth. Nonetheless, the joint venture aligns with the company’s long‑term strategy to shift from legacy product sales to subscription‑based services, potentially improving margins and investor confidence.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.